About Stem Cell Research

Since 2006 Stem Cell and Cancer Institute (SCI) has been doing many kinds of research in stem cell therapy and other cell therapy in collaboration with several educational hospitals and public universities to provide stem cell and cell therapy for degenerative disease and injury, such as osteoarthritis, non-union bone fracture, spinal cord injury, stroke, Parkinson, myocardial infarction, cardiomyopathy, and critical limb ischemia. In 2013, SCI built up Regenerative and Cellular Therapy (ReGeniC) under PT Bifarma Adiluhung which provides cell manufacturing facilities to support the needs of stem cell and cell therapy development and research. Since then, SCI has been doing much research in cellular therapy and active in research publications